Both proteasomes and lysosomes degrade the activated erythropoietin receptor

被引:131
作者
Walrafen, P
Verdier, F
Kadri, Z
Chrétien, S
Lacombe, C
Mayeux, P
机构
[1] Inst Cochin, Dept Hematol, INSERM, U567, F-75014 Paris, France
[2] Univ Paris 05, CNRS, UMR 8104, F-75270 Paris 06, France
[3] Assistance Publ Hop Paris, Hematol Lab, Hop Cochin, Paris, France
关键词
D O I
10.1182/blood-2004-03-1216
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Activation of the erythropoietin receptor (EpoR) after Epo binding is very transient because of the rapid activation of strong down-regulation mechanisms that quickly decrease Epo sensitivity of the cells. Among these down-regulation mechanisms, receptor internalization and degradation are probably the most efficient. Here, we show that the Epo receptor was rapidly ubiquitinated after ligand stimulation and that the C-terminal part of the Epo receptor was degraded by the proteasomes. Both ubiquitination and receptor degradation by the proteasomes occurred at the cell surface and required Janus kinase 2 (Jak2) activation. Moreover, Epo-EpoR complexes were rapidly internalized and targeted to the lysosomes for degradation. Neither Jak2 nor proteasome activities were required for internalization. In contrast, Jak2 activation was necessary for lysosome targeting of the Epo-EpoR complexes. Blocking Jak2 with the tyrphostin AG490 led to some recycling of internalized Epo-Epo receptor complexes to the cell surface. Thus, activated Epo receptors appear to be quickly degraded after ubiquitination by 2 proteolytic systems that proceed successively: the proteasomes remove part of the intracellular domain at the cell surface, and the lysosomes degrade the remaining part of the receptor-hormone complex. The efficiency of these processes probably explains the short duration of intracellular signaling activated by Epo.
引用
收藏
页码:600 / 608
页数:9
相关论文
共 53 条
[1]   FoxO3a regulates erythroid differentiation and induces BTG1, an activator of protein arginine methyl transferase 1 [J].
Bakker, WJ ;
Blázquez-Domingo, M ;
Kolbus, A ;
Besooyen, J ;
Steinlein, P ;
Beug, H ;
Coffer, PJ ;
Löwenberg, B ;
von Lindern, M ;
van Dijk, TB .
JOURNAL OF CELL BIOLOGY, 2004, 164 (02) :175-184
[2]   Activation of the erythropoietin receptor is not required for internalization of bound erythropoietin [J].
Beckman, DL ;
Lin, LL ;
Quinones, ME ;
Longmore, GD .
BLOOD, 1999, 94 (08) :2667-2675
[3]   Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation [J].
Bouscary, D ;
Pene, F ;
Claessens, YE ;
Muller, O ;
Chrétien, S ;
Fontenay-Roupie, M ;
Gisselbrecht, S ;
Mayeux, P ;
Lacombe, C .
BLOOD, 2003, 101 (09) :3436-3443
[4]   ERYTHROPOIETIN RECEPTOR CHARACTERISTICS ON PRIMARY HUMAN ERYTHROID-CELLS [J].
BROUDY, VC ;
LIN, N ;
BRICE, M ;
NAKAMOTO, B ;
PAPAYANNOPOULOU, T .
BLOOD, 1991, 77 (12) :2583-2590
[5]   CA074 METHYL-ESTER - A PROINHIBITOR FOR INTRACELLULAR CATHEPSIN-B [J].
BUTTLE, DJ ;
MURATA, M ;
KNIGHT, CG ;
BARRETT, AJ .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1992, 299 (02) :377-380
[6]   Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. [J].
Casadevall, N ;
Nataf, J ;
Viron, B ;
Kolta, A ;
Kiladjian, J ;
Martin-Dupont, P ;
Michaud, P ;
Papo, T ;
Ugo, V ;
Teyssandier, I ;
Varet, B ;
Mayeux, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (07) :469-475
[7]   Oncogenic epidermal growth factor receptor mutants with tandem duplication: gene structure and effects on receptor function [J].
Ciesielski, MJ ;
Fenstermaker, RA .
ONCOGENE, 2000, 19 (06) :810-820
[8]   The erythropoietin receptor: Structure, activation and intracellular signal transduction [J].
Constantinescu, SN ;
Ghaffari, S ;
Lodish, HF .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1999, 10 (01) :18-23
[9]   Internalization of the thrombopoietin receptor is regulated by 2 cytoplasmic motifs [J].
Dahlen, DD ;
Broudy, VC ;
Drachman, JG .
BLOOD, 2003, 102 (01) :102-108
[10]   Growth hormone receptor ubiquitination, endocytosis, and degradation are independent of signal transduction via Janus kinase 2 [J].
dos Santos, GMA ;
ten Broeke, T ;
Strous, GJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (35) :32635-32641